ImmunologybioRxivPreprint
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
M. McCallum, J. Bassi, A. De Marco…·D. Veesler
This study evaluates how the B.1.427/B.1.429 SARS-CoV-2 variant evades neutralizing antibodies through mutations in the RBD and NTD, showing reduced neutralization by both vaccine-induced and infection-derived antibodies.
DOI 10.1101/2021.03.31.437925